ArticleBlood advances2025
Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host disease.
Madelyn Espinosa-Cotton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it